24-sulfoximine vitamin D3 compounds

摘要

The present invention provides novel sulfoximine compounds, compositions comprising these compounds and methods of using these compounds as inhibitors of CYP24. In particular, the compounds of the invention are useful for treating diseases which benefit from a modulation of the levels of 1alpha,25-dihydroxy vitamin D3, for example, cell-proliferative disorders.